Clinical Trials Logo
  1. Home
  2. Intracranial Hemorrhages
  3. NCT05609110

Safety and Efficacy of Remote Ischemic Conditioning for Spontaneous Intracerebral Hemorrhage

Intracranial Hemorrhages Clinical Trial

Official title:
Safety and Efficacy of Remote Ischemic Conditioning for Spontaneous Intracerebral Hemorrhage

Clinical Trial Summary

The purpose of this study is to determine the efficacy and safety of remote ischemic conditioning in treating acute intracerebral hemorrhage.

Clinical Trial Description

Spontaneous intracerebral hemorrhage is a major cause of disability and mortality among different types of stroke, and few effective treatment options are available. Therefore, it is essential to develop new approaches to improve the prognosis of these patients. Recently, remote ischemic conditioning (RIC), a method that involves inducing multiple brief episodes of ischemia and reperfusion in the limbs, has been indicated to exert neuroprotective effects in experimental stroke. The underlying neuroprotective mechanism triggered by RIC induces gene expression, alters pathways, promotes neurogenesis and blood vessel development, reduces oxidative stress and neuronal apoptosis, and inhibits proinflammatory signals. Previously, several clinical trials have shown that single or repeated RIC treatments for cerebrovascular diseases are feasible and safe. Therefore, we hypothesize that RIC could improve functional outcome in patients with intracerebral hemorrhage. We design this prospective, multicenter, randomized controlled trial to evaluate the efficacy and safety of RIC in treating intracerebral hemorrhage. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05609110
Study type Interventional
Source The First Hospital of Jilin University
Contact Yi Yang, MD, PhD
Phone 13756661217
Email doctoryangyi@163.com
Status Recruiting
Phase N/A
Start date February 2, 2023
Completion date May 1, 2025
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT03969732 - Multimodal Biomarkers for Diagnosis and Prognosis in CAA Phase 3
Recruiting NCT05968053 - Detection of Microplastics and Nanoplastics in Neurosurgery Patients (DT-MiNi)
Recruiting NCT02962349 - TRansfusion Strategies in Acute Brain INjured Patients N/A
Recruiting NCT03950076 - EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF) Phase 4
Completed NCT03542656 - Application of Amyloid PET in Cerebral Amyloid Angiopathy Phase 3
Active, not recruiting NCT05626504 - Outcome Study of the Pipeline Embolization Device With Vantage Technology in Unruptured Aneurysms
Recruiting NCT03495206 - Safety, Tolerability and Pharmacokinetics of Y-2(Edaravone And Borneol) Sublingual Tablet Phase 1
Not yet recruiting NCT04229758 - Restarting Anticoagulation After Traumatic Intracranial Hemorrhage Phase 3
Recruiting NCT02135783 - Decompressive Craniectomy Combined With Hematoma Removal to Treat ICH N/A
Enrolling by invitation NCT02050971 - Autologous Cord Blood Infusion for the Prevention and Treatment of Prematurity Complications In Preterm Neonates Phase 1
Completed NCT01193270 - Vitamin E for Extremely Preterm Infants Phase 1
Completed NCT02881957 - Hypovitaminosis D in Neurocritical Patients Phase 2/Phase 3
Completed NCT03364634 - Intracranial Pressure After Decompressive Craniectomy N/A
Completed NCT00226096 - Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage N/A
Recruiting NCT06081283 - Antiseizure Medication in Seizure Networks at Early Acute Brain Injury Phase 4
Recruiting NCT04459806 - Intracranial PrEssure Time dOse (ImPETO)
Recruiting NCT05874050 - Arterial Pressure and Surgical Hemostasis in Elective Neurosurgery.
Not yet recruiting NCT05138341 - Minimal Invasive Surgical Intracerebral Hemorrhage Removal N/A
Terminated NCT03660618 - LSFG-SKIN, Laser Speckle Flowgraphy N/A
Not yet recruiting NCT06370520 - Screening Emotions in Adolescents at the Hospital for mTBI